Skip to main content
Dialysis treatment with the 5008 therapy system.

Fresenius Medical Care is the world’s leading provider of products and services for people with chronic kidney failure. About 3.8 million patients with this disease worldwide regularly undergo dialysis treatment. Dialysis is a vital blood cleansing procedure that substitutes the function of the kidney in case of kidney failure.

Through its network of about 4,100 dialysis clinics in North America, Europe, Latin America, Asia-Pacific and Africa, Fresenius Medical Care provides dialysis treatments for more than 343,000 patients around the globe. Fresenius Medical Care is also the world‘s leading provider of dialysis products such as hemodialysis machines, dialyzers and related disposable products.

The company's strategy is geared toward sustainable growth. Fresenius Medical Care aims to continuously improve the quality of life of patients with kidney disease by offering innovative products and treatment concepts of the highest quality.

Fresenius Medical Care’s corporate headquarters are in Bad Homburg v.d.H., Germany. The headquarters of North America are in Waltham, Massachusetts and the headquarters of Asia-Pacific are located in Hong Kong.

 

Fresenius Medical Care Corporate Movie

Key figures (IFRS)

€ millions 2021 2020 Growth

Sales

17,619 17,859 + 2 %

EBIT

1,915 2,499 - 21 %

Net income

1,018 1,359 - 23 %

Operating cash flow

2,489 4,233 - 41 %

Capital expenditures/acqusitions

1,482 1,459 + 2 %

R & D expenses

221 194 + 14 %

Employees (December 31)

130,251 133,129 - 2 %